SW six‑month net income $356M; April 2025 mill closures prompt impairments
Rhea-AI Filing Summary
Smurfit Westrock plc (SW) Q2 2025 highlights: The Combination closed July 5, 2024; net sales were $7,940 million for Q2 and $15,596 million for the six months ended June 30, 2025. Q2 reported a net loss of $26 million (basic EPS $(0.05)), while six-month net income was $356 million (EPS $0.68). Adjusted EBITDA (segment) totaled $1,247 million for Q2 and $2,536 million for six months. Impairment and restructuring charges were $280 million in Q2 ($184 million impairment, $96 million restructuring), largely tied to the April 30, 2025 announced closures.
Liquidity and balance sheet: Cash $778 million; operating cash flow for six months $1,064 million; capital expenditures $999 million; total assets $45,746 million; total liabilities $27,422 million; non-current debt $13,329 million. Dividends paid totaled $450 million for the six months. The purchase price allocation increased goodwill by $51 million to date.
Positive
- Combination closed July 5, 2024, creating a materially larger combined company with Smurfit Kappa shareholders owning ~50.3% and WestRock shareholders ~49.7%.
- Strong reported scale: Q2 net sales $7,940 million and six-month net sales $15,596 million, with segment Adjusted EBITDA of $1,247 million (Q2) and $2,536 million (six months).
- Operating cash flow: Net cash provided by operating activities was $1,064 million for the six months ended June 30, 2025.
- Investing to support capacity: Capital expenditures of $999 million in the six months signal substantial reinvestment into operations.
Negative
- Q2 GAAP loss: Net loss of $26 million and basic EPS of $(0.05) for the three months ended June 30, 2025.
- Impairment and restructuring: $280 million in Q2 (including $184 million impairment) primarily from April 2025 announced closures; an additional $45 million of charges expected through 2026.
- Elevated interest expense and leverage: Interest expense, net $182 million in Q2 ($349 million six months) and non-current debt of $13,329 million as of June 30, 2025.
- Cash decline and dividend outflow: Cash and equivalents decreased to $778 million; cash dividends paid totaled $450 million in the six-month period.
Insights
TL;DR: Combination rapidly scaled revenues and EBITDA but Q2 shows one-time impairments and higher interest costs, producing a small GAAP loss.
The Combination completed July 5, 2024 materially increased reported scale: Q2 net sales of $7.94 billion versus $2.97 billion prior-year quarter and six-month sales of $15.60 billion versus $5.90 billion. Segment Adjusted EBITDA rose to $1,247 million for Q2. However, GAAP results reflect $280 million of impairment and restructuring charges tied to announced closures, producing a Q2 net loss of $26 million. Interest expense rose materially (net interest expense $182 million Q2; $349 million six months), and leverage remains significant with non-current debt of $13.33 billion. This is impactful and merits close monitoring of synergy delivery, deleveraging and integration costs.
TL;DR: April 2025 facility closure program drove meaningful impairment and restructuring charges; further charges of $45 million are expected through 2026.
The April 30, 2025 announced closures triggered $176 million of impairments related to specific U.S. mills and related inventory, and restructuring costs recognized were $96 million in Q2 with $54 million attributable to those closures. Management expects an additional $45 million of charges related to these actions through 2026. These items are recorded within impairment and restructuring costs with majority expected to be paid within 12 months, affecting near-term cash outflows and operational capacity in affected regions.
FAQ
What were Smurfit Westrock (SW) net sales for Q2 2025?
Did Smurfit Westrock report a profit or loss in Q2 2025 (SW)?
What caused the impairment and restructuring charges in Smurfit Westrock's Q2 2025 results?
How much cash flow and capital expenditure did Smurfit Westrock report for the six months ended June 30, 2025?
What is Smurfit Westrock's (SW) debt position as of June 30, 2025?
AI-generated analysis. How Rhea-AI works. Not financial advice.
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
N/A | ||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
Large accelerated filer | ☐ | Accelerated filer | ☐ |
☒ | Smaller reporting company | ||
Emerging growth company | |||
Page | |
EXPLANATORY NOTE | 3 |
PART I - FINANCIAL INFORMATION | 6 |
Item 1. Financial Statements | 6 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 38 |
Item 3. Quantitative and Qualitative Disclosures About Market Risk | 54 |
Item 4. Controls and Procedures | 54 |
PART II - OTHER INFORMATION | 56 |
Item 1. Legal Proceedings | 56 |
Item 1A. Risk Factors | 56 |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 56 |
Item 3. Defaults Upon Senior Securities | 56 |
Item 4. Mine Safety Disclosures | 56 |
Item 5. Other Information | 56 |
Item 6. Exhibits | 57 |
Signatures | 58 |
Page | |
Condensed Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024 | 7 |
Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2025 and June 30, 2024 | 8 |
Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2025 and June 30, 2024 | 9 |
Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2025 and June 30, 2024 | 10 |
Condensed Consolidated Statements of Changes in Equity for the three and six months ended June 30, 2025 and June 30, 2024 | 11 |
Notes to the Condensed Consolidated Financial Statements | 13 |
June 30, 2025 | December 31, 2024 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents (amounts related to consolidated variable interest entities of $ $ | $ | $ | |
Accounts receivable, net (amounts related to consolidated variable interest entities of $ $ | |||
Inventories | |||
Other current assets | |||
Total current assets | |||
Property, plant and equipment, net | |||
Goodwill | |||
Intangibles, net | |||
Prepaid pension asset | |||
Other non-current assets (amounts related to consolidated variable interest entities of $ $ | |||
Total assets | $ | $ | |
Liabilities and Equity | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Accrued compensation and benefits | |||
Current portion of debt | |||
Other current liabilities | |||
Total current liabilities | |||
Non-current debt due after one year (amounts related to consolidated variable interest entities of $ million and $ | |||
Deferred tax liabilities | |||
Pension liabilities and other postretirement benefits, net of current portion | |||
Other non-current liabilities (amounts related to consolidated variable interest entities of $ and $ | |||
Total liabilities | |||
Commitments and Contingencies (Note 16) | |||
Equity: | |||
Preferred stock; $ | |||
Common stock; $ shares outstanding at June 30, 2025 and December 31, 2024, respectively | |||
Deferred shares; € 2025 and December 31, 2024, respectively | |||
Treasury stock; at cost; 2024, respectively | ( | ( | |
Capital in excess of par value | |||
Accumulated other comprehensive loss | ( | ( | |
Retained earnings | |||
Total shareholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net sales | $ | $ | $ | $ | |||
Cost of goods sold | ( | ( | ( | ( | |||
Gross profit | |||||||
Selling, general and administrative expenses | ( | ( | ( | ( | |||
Impairment and restructuring costs | ( | ( | |||||
Transaction and integration-related expenses associated with the Combination | ( | ( | ( | ( | |||
Operating profit | |||||||
Pension and other postretirement non-service income (expense), net | ( | ( | |||||
Interest expense, net | ( | ( | ( | ( | |||
Other (expense) income, net | ( | ( | |||||
Income before income taxes | |||||||
Income tax expense | ( | ( | ( | ( | |||
Net (loss) income | ( | ||||||
Net income attributable to noncontrolling interests | ( | ||||||
Net (loss) income attributable to common shareholders | $( | $ | $ | $ | |||
Basic (loss) earnings per share attributable to common shareholders | $( | $ | $ | $ | |||
Diluted (loss) earnings per share attributable to common shareholders | $( | $ | $ | $ | |||
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||||||
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net (loss) income | $( | $ | $ | $ | |||
Other comprehensive income (loss), net of tax: | |||||||
Foreign currency translation gain (loss) | ( | ( | |||||
Defined benefit pension and other postretirement benefit plans adjustments | ( | ( | |||||
Net (loss) gain on cash flow hedging derivatives | ( | ( | |||||
Other comprehensive income (loss), net of tax | ( | ( | |||||
Comprehensive income | |||||||
Comprehensive income attributable to noncontrolling interests | ( | ||||||
Comprehensive income attributable to common shareholders | $ | $ | $ | $ | |||
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||||||
Six months ended June 30, | |||
2025 | 2024 | ||
Operating activities: | |||
Net income | $ | $ | |
Adjustments to reconcile consolidated net income to net cash provided by operating activities: | |||
Depreciation, depletion and amortization | |||
Impairment charges | |||
Cash surrender value increase in excess of premiums paid | ( | ||
Share-based compensation expense | |||
Deferred income tax benefit | ( | ( | |
Pension and other postretirement funding more than cost | ( | ( | |
Other | ( | ||
Change in operating assets and liabilities, net of acquisitions and divestitures: | |||
Accounts receivable | ( | ( | |
Inventories | ( | ( | |
Other assets | ( | ( | |
Accounts payable | ( | ( | |
Income taxes | |||
Accrued liabilities and other | ( | ||
Net cash provided by operating activities | |||
Investing activities: | |||
Capital expenditures | ( | ( | |
Cash paid for purchase of businesses, net of cash acquired | ( | ( | |
Proceeds from sale of property, plant and equipment | |||
Other | |||
Net cash used for investing activities | ( | ( | |
Financing activities: | |||
Additions to debt | |||
Repayments of debt | ( | ( | |
Debt issuance costs | ( | ( | |
Changes in commercial paper, net | ( | ||
Other debt repayments, net | ( | ( | |
Repayments of finance lease liabilities | ( | ( | |
Tax paid in connection with shares withheld from employees | ( | ||
Purchases of treasury stock | ( | ||
Cash dividends paid to shareholders | ( | ( | |
Other | ( | ||
Net cash (used for) provided by financing activities | ( | ||
Effect of exchange rate changes on cash and cash equivalents | ( | ||
(Decrease) increase in cash and cash equivalents | ( | ||
Cash and cash equivalents at beginning of period | |||
Cash and cash equivalents at end of period | $ | $ | |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at March 31, 2025 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net loss | — | — | — | — | ( | — | ( | ( | |
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | — | — | ( | — | ( | — | ( |
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at June 30, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at March 31, 2024(1) | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | — | |||
Other comprehensive loss, net of tax | — | — | — | — | — | ( | ( | — | ( |
Share-based compensation | — | — | — | — | — | — | |||
Dividends declared ($ | — | — | — | — | ( | — | ( | — | ( |
Balance at June 30, 2024 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at December 31, 2024 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | — | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of deferred shares by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at June 30, 2025 | $ | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at December 31, 2023(1) | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | — | |||
Other comprehensive loss, net of tax | — | — | — | — | — | ( | ( | — | ( |
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Purchases of treasury stock | — | — | — | ( | — | — | ( | — | ( |
Issuance of common stock | — | — | — | — | — | — | — | ||
Dividends declared ($ | — | — | — | — | ( | — | ( | — | ( |
Balance at June 30, 2024 | $ | $ | $( | $ | $( | $ | $ | $ |
Three months ended | Six months ended | ||
June 30, 2024 | June 30, 2024 | ||
Net sales | $ | $ | |
Net income attributable to common shareholders |
Three months ended June 30, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $— | $ | ||
Add net sales (intersegment) | — | ||||||
Net sales (aggregate) | $ | $ | $ | $ | |||
Less segment expenses: | |||||||
Segment cost of goods sold | $( | $( | $( | — | |||
Segment selling, general and administrative expenses | ( | ( | ( | — | |||
$( | $( | $( | $( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Three months ended June 30, 2024 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $— | $ | ||
Add net sales (intersegment) | — | ||||||
Net sales (aggregate) | $ | $ | $ | $ | |||
Less segment expenses: | |||||||
Segment cost of goods sold | $( | $( | $( | — | |||
Segment selling, general and administrative expenses | ( | ( | ( | — | |||
$( | $( | $( | $( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service expense, net | ( | ||||||
Share-based compensation expense | ( | ||||||
Other income, net | |||||||
Income before income taxes | $ |
Six months ended June 30, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | $ | $ | $ | $ | |||
Less segment expenses: | |||||||
Segment cost of goods sold | $( | $( | $( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
$( | $( | $( | $( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Six months ended June 30, 2024 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | $ | $ | $ | $ | |||
Less segment expenses: | |||||||
Segment cost of goods sold | $( | $( | $( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
$( | $( | $( | $( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service expense, net | ( | ||||||
Share-based compensation expense | ( | ||||||
Other adjustments | |||||||
Income before income taxes | $ |
Six months ended June 30, | |||
2025 | 2024 | ||
Capital expenditures: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total reportable segments | $ | $ | |
Corporate | |||
Total capital expenditures | $ | $ | |
June 30, | December 31, | ||
2025 | 2024 | ||
Assets: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total reportable segments | $ | $ | |
Corporate(1) | |||
Total assets | $ | $ |
Three months ended June 30, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Three months ended June 30, 2024 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Six months ended June 30, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Six months ended June 30, 2024 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Contract Assets (Short-Term) | Contract Liabilities (Short-Term) | ||
Balance at December 31, 2024 | $ | $ | |
Decrease | ( | ||
Balance at June 30, 2025 | $ | $ |
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Impairment charges | $ | $ | $ | $ | |||
Restructuring costs | |||||||
Impairment and restructuring costs | $ | $ | $ | $ | |||
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Impairment of property, plant and equipment | $ | $ | $ | $ | |||
Impairment of other assets | |||||||
Impairment charges | $ | $ | $ | $ | |||
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Severance charges | $ | $ | $ | $ | |||
Other costs | — | — | — | ||||
Restructuring costs | $ | $ | $ | $ | |||
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Transaction-related expenses associated with the Combination | $ | $( | $ | $( | |||
Integration-related expenses associated with the Combination | ( | ( | |||||
Total transaction and integration-related expenses associated with the Combination | $( | $( | $( | $( | |||
June 30, | December 31, | ||
2025 | 2024 | ||
Gross accounts receivable | $ | $ | |
Less: Allowances | ( | ( | |
Accounts receivable, net | $ | $ |
June 30, | December 31, | ||
2025 | 2024 | ||
Finished goods | $ | $ | |
Work-in-progress | |||
Raw materials | |||
Consumables and spare parts | |||
Inventories | $ | $ |
June 30, | December 31, | ||
2025 | 2024 | ||
Land and buildings | $ | $ | |
Plant and equipment | |||
Construction-in-progress | |||
Finance lease right-of-use assets | |||
Property, plant and equipment at cost, excluding forestlands | |||
Less: Accumulated depreciation and impairment | ( | ( | |
Property, plant and equipment, net, excluding forestlands | $ | $ | |
Forestlands, net of depletion | |||
Property, plant and equipment, net | $ | $ |
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Interest expense | $( | $( | $( | $( | |||
Interest income | |||||||
Interest expense, net | $( | $( | $( | $( | |||
June 30, 2025 | December 31, 2024 | ||||||
Book Value | Fair Value | Book Value | Fair Value | ||||
Debt with fixed interest rates | $ | $ | $ | $ | |||
Level 1 | Level 2 | ||||||
June 30, | December 31, | June 30, | December 31, | ||||
2025 | 2024 | 2025 | 2024 | ||||
Assets | |||||||
Other Investments: | |||||||
Listed | $ | $ | $ | $ | |||
Unlisted | |||||||
Derivatives in cash flow hedging relationships | |||||||
Derivatives not designated as hedging instruments | |||||||
Assets measured at fair value | $ | $ | $ | $ | |||
Liabilities | |||||||
Derivatives in cash flow hedging relationships | $ | $ | $ | $ | |||
Derivatives not designated as hedging instruments | |||||||
Liabilities measured at fair value | $ | $ | $ | $ | |||
Receivable from financial institutions at December 31, 2024 | $ |
Receivables sold to the financial institutions and derecognized | ( |
Receivables collected by financial institutions | |
Cash payments to financial institutions | ( |
Receivable from financial institutions at June 30, 2025 | $ |
June 30, | December 31, | ||
2025 | 2024 | ||
$ | $ | $ | |
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
€ | |||
€ | |||
€ | |||
$ | |||
$ | |||
$ | |||
$ | |||
$ | |||
$ | |||
€ | |||
€ | |||
$ | |||
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
$ | |||
Commercial paper | |||
Vendor financing and commercial card programs | |||
Term loan facilities | |||
Bank loans | |||
Finance lease obligations | |||
Bank overdrafts | |||
Total debt, excluding debt issuance costs | |||
Debt issuance costs | ( | ( | |
Total debt | |||
Less: Current portion of debt | ( | ( | |
Non-current debt due after one year | $ | $ |
Defined Benefit Pension Plans | Defined Benefit Pension Plans | ||||||||||||||
U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | ||||||||||||
Three months ended June 30, | Six months ended June 30, | ||||||||||||||
2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | ||||||||
Service cost | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Interest cost | |||||||||||||||
Expected return on assets | ( | ( | ( | ( | ( | ( | ( | ||||||||
Amortization of: | |||||||||||||||
Net actuarial loss | |||||||||||||||
Prior service credit | ( | ||||||||||||||
Settlement loss | |||||||||||||||
Net periodic benefit (income) cost | $( | $ | $ | $ | $( | $ | $ | $ | |||||||
Other Postretirement Benefit Plans | Other Postretirement Benefit Plans | ||||||
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Service cost | $ | $ | $ | $ | |||
Interest cost | |||||||
Net periodic benefit cost | $ | $ | $ | $ | |||
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Defined Benefit Pension Plans Contributions | $ | $ | $ | $ | |||
Other Postretirement Benefit Plans Contributions | |||||||
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Numerator: | |||||||
Net (loss) income attributable to common shareholders | $( | $ | $ | $ | |||
Denominator: | |||||||
Basic weighted average shares outstanding | |||||||
Effect of dilutive share options | |||||||
Diluted weighted average shares outstanding | |||||||
Basic (loss) earnings per share attributable to common shareholders | $( | $ | $ | $ | |||
Diluted (loss) earnings per share attributable to common shareholders | $( | $ | $ | $ | |||
Shares | |||||||
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Performance stock units | |||||||
Restricted stock units | |||||||
Total antidilutive shares | |||||||
June 30, | December 31, | ||
2025 | 2024 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Accounts receivable | |||
Other current assets | |||
Non-current assets: | |||
Property, plant and equipment, net | |||
Other non-current assets | |||
Total assets | $ | $ | |
Liabilities | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Current portion of debt | |||
Other current liabilities | |||
Non-current liabilities: | |||
Non-current debt due after one year | |||
Other non-current liabilities | |||
Total liabilities | $ | $ |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Postretirement Plans | Other Reserves(1) | Total(2) | |
Balance at March 31, 2024 | $ | $ | $ | $( | $ |
Other comprehensive loss (income) | ( | ( | |||
Balance at June 30, 2024 | $ | $ | $ | $( | $ |
Balance at March 31, 2025 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | |||
Balance at June 30, 2025 | $ | $ | $ | $( | $ |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Postretirement Plans | Other Reserves(1) | Total(2) | |
Balance at December 31, 2023 | $ | $ | $ | $( | $ |
Other comprehensive loss (income) | ( | ( | |||
Balance at June 30, 2024 | $ | $ | $ | $( | $ |
Balance at December 31, 2024 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | |||
Balance at June 30, 2025 | $ | $ | $ | $( | $ |
Three months ended June 30, | |||||||
2025 | 2024 | ||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | ||
Foreign currency translation gain (loss) | $ | $ | $ | $( | $ | $( | |
Defined benefit pension and other post-retirement benefit plans: | |||||||
Net actuarial loss arising during period | ( | ( | |||||
Amortization and settlement recognition of net actuarial loss | ( | ( | |||||
Prior service cost arising during period | ( | ( | |||||
Foreign currency (loss) gain - pensions | ( | ( | |||||
Derivatives: | |||||||
Changes in fair value of cash flow hedges | ( | ( | |||||
Consolidated other comprehensive income (loss) | ( | ( | ( | ||||
Less: Other comprehensive (income) loss attributable to noncontrolling interests | |||||||
Other comprehensive income (loss) attributable to common shareholders | $ | $ | $ | $( | $( | $( | |
Six months ended June 30, | |||||||
2025 | 2024 | ||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | ||
Foreign currency translation gain (loss) | $ | $ | $ | $( | $ | $( | |
Defined benefit pension and other post-retirement benefit plans: | |||||||
Net actuarial loss arising during period | ( | ( | ( | ( | |||
Amortization and settlement recognition of net actuarial loss | ( | ( | |||||
Prior service cost arising during period | ( | ( | |||||
Amortization of prior service credit | ( | ( | |||||
Foreign currency (loss) gain - pensions | ( | ( | |||||
Derivatives: | |||||||
Changes in fair value of cash flow hedges | ( | ( | |||||
Consolidated other comprehensive income (loss) | ( | ( | ( | ||||
Less: Other comprehensive (income) loss attributable to noncontrolling interests | |||||||
Other comprehensive income (loss) attributable to common shareholders | $ | $ | $ | $( | $( | $( | |
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net sales | $7,940 | $2,969 | $15,596 | $5,899 | |||
Cost of goods sold | (6,425) | (2,276) | (12,504) | (4,496) | |||
Gross profit | 1,515 | 693 | 3,092 | 1,403 | |||
Selling, general and administrative expenses | (963) | (389) | (1,936) | (769) | |||
Impairment and restructuring costs | (280) | — | (295) | — | |||
Transaction and integration-related expenses associated with the Combination | (21) | (60) | (57) | (83) | |||
Operating profit | 251 | 244 | 804 | 551 | |||
Pension and other postretirement non-service income (expense), net | 7 | (29) | 16 | (39) | |||
Interest expense, net | (182) | (33) | (349) | (58) | |||
Other (expense) income, net | (18) | 5 | (23) | — | |||
Income before income taxes | 58 | 187 | 448 | 454 | |||
Income tax expense | (84) | (55) | (92) | (131) | |||
Net (loss) income | (26) | 132 | 356 | 323 | |||
Net income attributable to noncontrolling interests | (2) | — | — | — | |||
Net (loss) income attributable to common shareholders | $(28) | $132 | $356 | $323 | |||
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net sales (aggregate):(1) | |||||||
North America | $4,755 | $438 | $9,424 | $850 | |||
Europe, MEA and APAC | 2,778 | 2,211 | 5,360 | 4,405 | |||
LATAM | 518 | 340 | 1,031 | 681 | |||
Segment Adjusted EBITDA: | |||||||
North America | $752 | $61 | $1,537 | $120 | |||
Europe, MEA and APAC | 372 | 362 | 761 | 747 | |||
LATAM | 123 | 87 | 238 | 141 | |||
Six months ended June 30, | ||
2025 | 2024 | |
Net cash provided by operating activities | $1,064 | $382 |
Net cash used for investing activities | $(996) | $(410) |
Net cash (used for) provided by financing activities | $(204) | $2,382 |
Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net (loss) income | $(26) | $132 | $356 | $323 | |||
Income tax expense | 84 | 55 | 92 | 131 | |||
Depreciation, depletion and amortization | 613 | 160 | 1,216 | 308 | |||
Impairment and restructuring costs | 280 | — | 295 | — | |||
Transaction and integration-related expenses associated with the Combination | 21 | 60 | 57 | 83 | |||
Interest expense, net | 182 | 33 | 349 | 58 | |||
Pension and other postretirement non-service (income) expense, net | (7) | 29 | (16) | 39 | |||
Share-based compensation expense | 36 | 16 | 79 | 31 | |||
Other expense (income), net | 18 | (5) | 23 | — | |||
Other adjustments | 12 | — | 14 | (18) | |||
Adjusted EBITDA | $1,213 | $480 | $2,465 | $955 | |||
SUMMARIZED STATEMENT OF OPERATIONS | Six months ended June 30, |
2025 | |
Net sales to unrelated parties | $743 |
Net sales to non-Guarantor Subsidiaries | 625 |
Gross profit | 491 |
Interest expense, net with unrelated parties | (308) |
Interest expense, net with non-Guarantor Subsidiaries | (173) |
Net income and net income attributable to the Obligor Group | 457 |
SUMMARIZED BALANCE SHEETS | June 30, | December 31, | |
2025 | 2024 | ||
ASSETS | |||
Current amounts due from non-Guarantor Subsidiaries | $5,459 | $4,925 | |
Other current assets | 854 | 1,049 | |
Total current assets | $6,313 | $5,974 | |
Non-current amounts due from non-Guarantor Subsidiaries | $2,855 | $2,848 | |
Other non-current assets | 385 | 370 | |
Total non-current assets | $3,240 | $3,218 | |
LIABILITIES | |||
Current amounts due to non-Guarantor Subsidiaries | $7,964 | $9,681 | |
Other current liabilities | 1,162 | 1,122 | |
Total current liabilities | $9,126 | $10,803 | |
Non-current amounts due to non-Guarantor Subsidiaries | $6,626 | $6,604 | |
Other non-current liabilities | 11,683 | 9,644 | |
Total non-current liabilities | $18,309 | $16,248 |
Exhibit Number | Description of Exhibit | ||
3.1 | Amended Constitution of Smurfit Westrock plc (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed on July 8, 2024). | ||
10.1† | WestRock Company 2016 Deferred Compensation Plan for Non-Employee Directors (as amended). | ||
22† | List of Guarantor Subsidiaries and Issuers of Guaranteed Securities. | ||
31.1† | Certification of the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
31.2† | Certification of the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
32†* | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.** | ||
101.SCH | Inline XBRL Taxonomy Extension Schema.** | ||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase.** | ||
101.DEF | Inline XBRL Taxonomy Extension Definition Document.** | ||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase.** | ||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase.** | ||
104 | Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
Smurfit Westrock plc | ||
Dated: August 7, 2025 | /s/ Anthony Smurfit | |
Name: | Anthony Smurfit | |
Title: | President & Group Chief Executive Officer | |
(Principal Executive Officer) | ||
Smurfit Westrock plc | ||
Dated: August 7, 2025 | /s/ Ken Bowles | |
Name: | Ken Bowles | |
Title: | Executive Vice President & Group Chief Financial Officer | |
(Principal Financial Officer) | ||